Nagi Bioscience
About:
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested.
Website: http://nagibio.ch/
Twitter/X: Nagibioscience
Top Investors: Verve Ventures, Venture Kick, European Innovation Council, imec.xpand, Zürcher Kantonal Bank
Description:
Nagi Bioscience aims to revolutionize the way toxic and/or beneficial effects of substances are tested today, by introducing the first “Organism-on-Chip” technology.
Total Funding Amount:
$18.3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Lausanne, Vaud, Switzerland
Founded Date:
2019-01-01
Contact Email:
info(AT)nagibio.ch
Founders:
Laurent Mouchiroud, Matteo Cornaglia
Number of Employees:
11-50
Last Funding Date:
2023-09-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai